Inventor · disambiguated record
Herve Bouchard
Also filed as: BOUCHARD HERVE · Bouchard Hervé
57 granted patents·16 pending applications·1,791 citations·filing 1993–2024
99Inventor score
Top patents by PatentIndex Score
73 records- 0198US6479479B2Azetidine derivatives, their preparation and pharmaceutical compositions containing themAVENTIS PHARMA SA·Filed 2001·Granted Nov 12, 2002·81 cites·58 claims
- 0297US6355631B1Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and their preparationAVENTIS PHARMA SA·Filed 2001·Granted Mar 12, 2002·107 cites·21 claims
- 0396US8288425B2BenzimidazolesEDWARDS MICHAEL L·Filed 2005·Granted Oct 16, 2012·123 cites·18 claims
- 0496US6897208B2BenzimidazolesAVENTIS PHARMA INC·Filed 2002·Granted May 24, 2005·168 cites·38 claims
- 0596US5847170ATaxoids, their preparation and pharmaceutical compositions containing themRHONE POULENC RORER SA·Filed 1996·Granted Dec 8, 1998·94 cites·22 claims
- 0695US9617345B2Anti-CEACAM5 antibodies and uses thereofSANOFI SA·Filed 2015·Granted Apr 11, 2017·53 cites·20 claims
- 0795US6897207B2AzaindolesAVENTIS PHARMA INC·Filed 2002·Granted May 24, 2005·120 cites·50 claims
- 0894US8163736B2Cytotoxic agents comprising new tomaymycin derivativesGAUZY LAURENCE·Filed 2008·Granted Apr 24, 2012·151 cites·24 claims
- 0994US6566356B2Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparationAVENTIS PHARMA SA·Filed 2001·Granted May 20, 2003·60 cites·18 claims
- 1094US6518264B2Azetidine derivatives, their preparation and medicaments containing themAVENTIS PHARMA SA·Filed 2001·Granted Feb 11, 2003·68 cites·41 claims
- 1193US5728849ATaxoids their preparation and pharmaceutical compositions containing themRHONE POULENC RORER SA·Filed 1996·Granted Mar 17, 1998·99 cites·16 claims
- 1292US7943616B2Azaindoles for inhibiting aurora2 and other kinasesAVENTIS PHARMA INC·Filed 2004·Granted May 17, 2011·61 cites·1 claims
- 1392US6734176B2Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparationAVENTIS PHARMA SA·Filed 2002·Granted May 11, 2004·47 cites·9 claims
- 1491US11332542B2Anti-CEACAM5 antibodies and uses thereofSANOFI SA·Filed 2019·Granted May 17, 2022·4 cites·11 claims
- 1591US8952147B2Conjugates, preparation thereof, and therapeutic use thereofBouchard Hervé·Filed 2011·Granted Feb 10, 2015·54 cites·39 claims
- 1691US8404678B2Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic useBOUCHARD HERVE·Filed 2010·Granted Mar 26, 2013·36 cites·28 claims
- 1790US6872717B2Pharmacological uses of azetidine derivativesAVENTIS PHARMA SA·Filed 2002·Granted Mar 29, 2005·35 cites·13 claims
- 1890US6372780B2Methods of treating cell lines expressing multidrug resistance P-glycoproteinAVENTIS PHARMA SA·Filed 2001·Granted Apr 16, 2002·25 cites·14 claims
- 1989US6858603B2Acetindine derivatives, their preparation and medicaments containing themAVENTIS PHARMA SA·Filed 2002·Granted Feb 22, 2005·28 cites·20 claims
- 2088US6387946B1Methods for treating pathological conditions of abnormal cell proliferationAVENTIS PHARMA SA·Filed 2001·Granted May 14, 2002·26 cites·8 claims
- 2187US10457739B2Anti-CEACAM5 antibodies and uses thereofSANOFI SA·Filed 2017·Granted Oct 29, 2019·6 cites·40 claims
- 2286US7354933B2Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitorsAVENTIS PHARMA SA·Filed 2004·Granted Apr 8, 2008·27 cites·58 claims
- 2385US5532388ATaxoids, their preparation and pharmaceutical compositions containing themRHONE POULENC RORER SA·Filed 1995·Granted Jul 2, 1996·40 cites·20 claims
- 2484US7816543B2Leptomycin derivativesSANOFI AVENTIS·Filed 2008·Granted Oct 19, 2010·5 cites·17 claims
- 2584US6232477B1Methods of preparing new taxoids and pharmaceutical compositions containing themAVENTIS PHARMA SA·Filed 2000·Granted May 15, 2001·14 cites·12 claims
- 2683US5814658ATaxoids, their preparation and pharmaceutical compositions containing themRHONE POULENC RORER SA·Filed 1995·Granted Sep 29, 1998·20 cites·29 claims
- 2783US2025205348A1Novel peptidic linkers and cryptophycin conjugates, their preparation and their therapeutic useSANOFI SA·Filed 2024·Application pending·0 cites
- 2881US10941139B2Cryptophycin compounds and conjugates, their preparation and their therapeutic useSANOFI SA·Filed 2016·Granted Mar 9, 2021·2 cites·53 claims
- 2981US6593482B2Methods for preparing new taxoids and pharmaceutical compositions containing themAVENTIS PHARMA SA·Filed 2001·Granted Jul 15, 2003·11 cites·39 claims
- 3080US11007275B2Cryptophycin antibody conjugates for the treatment of cancerSANOFI SA·Filed 2019·Granted May 18, 2021·1 cites·20 claims
- 3180US8668910B2Antibodies that specifically bind to the EphA2 receptorBOUCHARD HERVE·Filed 2010·Granted Mar 11, 2014·5 cites·25 claims
- 3279US5906990ATaxoids, preparation thereof, and pharmaceutical compositions containing sameRHONE POULENC RORER SA·Filed 1996·Granted May 25, 1999·26 cites·25 claims
- 3378US7132414B2Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparationAVENTIS PHARMA SA·Filed 2004·Granted Nov 7, 2006·9 cites·6 claims
- 3478US6995175B2Chemical derivatives and their application as antitelomerase agentAVENTIS PHARMA SA·Filed 2003·Granted Feb 7, 2006·7 cites·29 claims
- 3578US5889043ATaxoids, preparation thereof and pharmaceutical Compositions containing sameRHONE POULENC RORER SA·Filed 1996·Granted Mar 30, 1999·37 cites·30 claims
- 3677US6331635B1Taxoids, their preparation and pharmaceutical compositions containing themAVENTIS PHARMA SA·Filed 1998·Granted Dec 18, 2001·33 cites·25 claims
- 3775US9676864B2Antibodies that specifically bind to the EphA2 receptorSANOFI SA·Filed 2014·Granted Jun 13, 2017·2 cites·19 claims
- 3873US7517902B2Substituted indazoles, compositions containing the same, and the preparation and use thereofAVENTIS PHARMA SA·Filed 2006·Granted Apr 14, 2009·2 cites·23 claims
- 3971US11998611B2Cryptophycin antibody conjugates for the treatment of cancerSANOFI SA·Filed 2021·Granted Jun 4, 2024·0 cites·17 claims
- 4071US7825115B2Cyclic urea compounds, preparation thereof and pharmaceutical use thereof as kinase inhibitorsAVENTIS PHARMA SA·Filed 2008·Granted Nov 2, 2010·1 cites·56 claims
- 4171US6384071B2Taxoids, their preparation and pharmaceutical compositions containing themAVENTIS PHARMA SA·Filed 2001·Granted May 7, 2002·3 cites·12 claims
- 4270US7435820B2Substituted tetrahydro-1H-pyrazolo [3,4-c]pyridines compositions comprising them, and useAVENTIS PHARMA SA·Filed 2006·Granted Oct 14, 2008·1 cites·11 claims
- 4369US7759379B2Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitorsAVENTIS PHARMA SA·Filed 2007·Granted Jul 20, 2010·1 cites·18 claims
- 4469US6815437B1Streptogramines, their preparation and compositions containing themAVENTIS PHARMA SA·Filed 2000·Granted Nov 9, 2004·2 cites·17 claims
- 4568US6380197B1Polyhydroxyalkylpyrazine derivatives, their preparation and medicaments containing themAVENTIS PHARMA SA·Filed 2000·Granted Apr 30, 2002·1 cites·21 claims
- 4665US7074821B1Taxoids, their preparation and pharmaceutical composition containing themAVENTIS PHARMA SA·Filed 1993·Granted Jul 11, 2006·9 cites·15 claims
- 4765US5606083AProcess for the preparation of taxane derivatives, new derivatives thus obtained and the compositions which contain themRHONE POULENC RORER SA·Filed 1993·Granted Feb 25, 1997·18 cites·25 claims
- 4864US2009253697A1Novel Indole Derivatives, Preparation Thereof as Medicinal Products and Pharmaceutical Compositions, and Especially as KDR InhibitorsAVENTIS PHARMA SA·Filed 2009·Application pending·0 cites
- 4963US2020093934A1Novel peptidic linkers and cryptophycin conjugates, their preparation and their therapeutic useSANOFI SA·Filed 2018·Application pending·0 cites
- 5061US5959125ATaxoids, preparation thereof, and pharmaceutical compositions containing sameRHONE POULENC RORER SA·Filed 1996·Granted Sep 28, 1999·18 cites·19 claims
Showing the top 50 of 73 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Herve Bouchard files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →